Loading
JPXConsumer DefensiveHousehold & Personal Products
Latest quote
¥5,695
−¥6.00 · -0.11%
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Latest quote
¥5,695
−¥6.00 · -0.11%
Regular session · JST · Market data may be delayed.
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Day range
Current ¥5,695
52-week range
Current ¥5,695
Regular session · JST · Market data may be delayed.
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Day range
Current ¥5,695
52-week range
Current ¥5,695
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 165.74B JPY | 165.6B JPY | 173.46B JPY | 166.26B JPY | 155.25B JPY |
| Cost of goods sold | 81.03B JPY | 78B JPY | 77.08B JPY | 73.93B JPY | 66.48B JPY |
| Gross profit | 84.71B JPY | 87.6B JPY | 96.38B JPY | 92.33B JPY | 88.77B JPY |
| Research and development | 9.12B JPY | 9.11B JPY | 9B JPY | 8.33B JPY | 7.52B JPY |
| Selling, general, and administrative | 54.21B JPY | 48.19B JPY | 57.61B JPY | 54.07B JPY | 52.19B JPY |
| Operating expenses | 69.79B JPY | 62.74B JPY | 70.6B JPY | 65.66B JPY | 62.71B JPY |
| Interest income | 335M JPY | 207M JPY | 214M JPY | 85M JPY | 131M JPY |
| Interest expense | 28M JPY | 28M JPY | 29M JPY | 18M JPY | 18M JPY |
| Depreciation and amortization | 8.75B JPY | 8.02B JPY | 6.06B JPY | 5.36B JPY | 4.84B JPY |
| Operating income | 14.92B JPY | 24.86B JPY | 25.78B JPY | 26.67B JPY | 26.07B JPY |
| Net income | 3.66B JPY | 10.07B JPY | 20.34B JPY | 20.02B JPY | 19.72B JPY |
Company facts updated Sep 6, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T859.68M0.03%2.9T JPY0.05%¥421.6+0.12%
Vanguard Total International Stock ETFVXUS25.69M0.00%646.2B USD0.05%$88.41+0.50%
Vanguard FTSE Developed Markets ETFVEA17.63M0.01%315B USD0.03%$73.76+0.44%
iShares Core MSCI EAFE ETFIEFA13.09M0.01%193.86B USD0.07%$101.08+0.13%
iShares MSCI EAFE Small-Cap ETFSCZ6.34M0.05%13.11B USD0.40%$87.57+0.10%
Schwab International Equity ETFSCHF4.62M0.01%69.05B USD0.03%$28.58+0.42%
Vanguard FTSE All-World ex-US ETFVEU4.09M0.00%95.9B USD0.04%$86.41+0.54%
Vanguard International Dividend Appreciation ETFVIGI3.1M0.03%9.4B USD0.07%$99.4316-0.39%iShares Core TOPIX ETF1475.TVanguard Total International Stock ETFVXUSVanguard FTSE Developed Markets ETFVEAiShares Core MSCI EAFE ETFIEFAiShares MSCI EAFE Small-Cap ETFSCZSchwab International Equity ETFSCHFVanguard FTSE All-World ex-US ETFVEUVanguard International Dividend Appreciation ETFVIGIAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
